Insertions and Deletions in HIV-1 Reverse Transcriptase: Consequences for Drug Resistance and Viral Fitness

E-ISSN： 1873-4286|12|15|1811-1825

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.15, 2006-01, pp. : 1811-1825

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combinations Against Combinations: Associations of Anti-HIV 1 Reverse Transcriptase Drugs Challenged by Constellations of Drug Resistance Mutations

Current Drug Metabolism, Vol. 3, Iss. 1, 2002-02 ,pp. : 73-95

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: HIV-1 Reverse Transcriptase Inhibitors: Drug Resistance and Drug Development (Executive Editors: Nicolas Sluis-Cremer and Ted Ross)]

Current Pharmaceutical Design, Vol. 12, Iss. 15, 2006-05 ,pp. : 1809-1810

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Insights into the Mechanisms of HIV-1 Reverse Transcriptase Resistance to Nucleoside Analogs

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 5, 2006-05 ,pp. : 549-555

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Resistance, Virus Fitness and HIV-1 Mutagenesis

Current Pharmaceutical Design, Vol. 10, Iss. 32, 2004-12 ,pp. : 4065-4070

Bentham Science Publishers

Access to resources Recommend Favorite

HIV-1 reverse transcriptase inhibitors

By Krawczyk Sören Hilgeroth Andreas

PHARMAKON, Vol. 2, Iss. 4, 2014-07 ,pp. : 270-276

Govi-Verlag

Access to resources Recommend Favorite